2-(Piperazin-1-yl)acetic acid hydrochloride

Catalog No.: 
ACPART189
CAS No.: 
1222197-25-2
Molecular Formula: 
C6H13ClN2O2
Molecular Weight: 
180.63
2-(Piperazin-1-yl)acetic acid hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$89.00InquiryInquiry
1g95%$178.00InquiryInquiry
5g95%$534.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Piperazin-1-yl)acetic acid hydrochloride
IUPAC Name2-(piperazin-1-yl)acetic acid hydrochloride
MDL No.MFCD27976336
Molecular FormulaC6H13ClN2O2
Molecular Weight180.63
SMILESO=C(O)CN1CCNCC1.[H]Cl
InChI KeyPVAOJNMPNQIMFT-UHFFFAOYSA-N
Synonym2-(piperazin-1-yl)acetic acid hydrochloride;1-Piperazineacetic acid, hydrochloride (1:1);2-(Piperazin-1-yl)acetic acid HCl
CAS No.1222197-25-2
PubChem CID67009840

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACPART189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPDIE017 route compound structure diagram
    ACPDIE017112257-22-4In Stock
  2. Then
  3. ACPART189 route product structure diagram
    ACPART1891222197-25-2
Inquiry

2. ACPART189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEUMO414 route compound structure diagram
    ACEUMO41459813-05-7
  2. Plus
  3. ACKSZQ125 route compound structure diagram
    ACKSZQ12593556-88-8In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACPART189 route product structure diagram
    ACPART1891222197-25-2
Inquiry

3. ACPART189 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFPFL382 route compound structure diagram
    ACFPFL382126231-77-4
  2. Then
  3. ACPART189 route product structure diagram
    ACPART1891222197-25-2
Inquiry

Comments (0)